News

Filter by Category

Filter by Program

Filter by Publish Date

March 10, 2025

C-Path’s Critical Path for Parkinson’s Consortium Welcomes CND Life Sciences

C-Path is excited to welcome CND Life Sciences as the newest member of it Critical Path for Parkinson’s (CPP)...

February 20, 2025

Critical Path for Parkinson's Consortium (CPP) Advisor and FDA Advisory Committee Member Sarah Zenner-Dolan...

February 19, 2025

At C-Path’s INC, we believe that meaningful progress in neonatal drug development...

February 19, 2025

C-Path's eCOA Consortium is thrilled to welcome Veeva Systems and VPG Health...

February 18, 2025

Critical Path for Alpha-1 (CPA-1) consortium today announced the addition of biopharmaceutical companies, Kamada and Sanofi.

February 13, 2025

Pediatric drug development faces signiﬁcant challenges, including underfunding, ethical concerns, and complex regulatory...

January 31, 2025

C-Path has developed a framework to support FDA qualification of CIVMs for use in regulatory submissions.

February 20, 2025

Join Julie Wood, Chief Operating Officer at Vivli, for an engaging webinar, Thursday, February 20, where she’ll discuss...

January 21, 2025

We are thrilled to invite you to the 2025 Critical Path Institute® (C-Path) Global Impact Conference (CGIC)...

January 17, 2025

The Foundation for the National Institutes of Health (FNIH) and Critical Path Institute® (C-Path)...